ENOV - Enovis Corporation Stock Price, Fair Value and News

$34.99+2.39 (+7.33%)

Delayed as of 23 Apr 2025, 11:06 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ENOV Price Action

Last 7 days

3.6%

Last 30 days

-16.6%

Last 90 days

-30.7%

Trailing 12 Months

-41.3%

ENOV RSI Chart

ENOV Valuation

Market Cap

1.9B

Price/Earnings (Trailing)

-2.25

Price/Sales (Trailing)

0.88

EV/EBITDA

-6.48

Price/Free Cashflow

-27.63

ENOV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ENOV Fundamentals

ENOV Revenue

Revenue (TTM)

2.1B

Rev. Growth (Yr)

23.29%

Rev. Growth (Qtr)

11.04%

ENOV Earnings

Earnings (TTM)

-825.4M

Earnings Growth (Yr)

-25.4K%

Earnings Growth (Qtr)

-2.1K%

ENOV Profitability

EBT Margin

-39.05%

Return on Equity

-32.21%

Return on Assets

-17.49%

Free Cashflow Yield

-3.62%

ENOV Investor Care

Shares Dilution (1Y)

4.29%

Diluted EPS (TTM)

-14.93

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.8B	1.9B	2.0B	2.1B
2023	1.6B	1.6B	1.7B	1.7B
2022	1.5B	1.5B	1.6B	1.6B
2021	2.6B	2.3B	1.9B	1.4B
2020	3.5B	3.2B	3.1B	3.1B
2019	2.3B	2.7B	3.0B	3.3B
2018	3.1B	2.8B	2.5B	2.2B
2017	3.2B	3.2B	3.2B	3.3B
2016	3.8B	3.6B	3.4B	3.2B
2015	4.5B	4.3B	4.1B	4.0B
2014	4.3B	4.4B	4.6B	4.6B
2013	4.0B	4.0B	4.1B	4.2B
2012	1.4B	2.3B	3.1B	3.9B
2011	580.6M	644.4M	682.3M	693.4M
2010	0	530.7M	536.3M	542.0M
2009	0	0	0	525.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Enovis Corporation

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

CEO	Mr. Matthew L. Trerotola
WEBSITE	enovis.com
SECTOR	Industrials
INDUSTRY	Specialty Industrial Machinery
EMPLOYEES	6800

Enovis Corporation Frequently Asked Questions

What is the ticker symbol for Enovis Corporation? What does ENOV stand for in stocks?

ENOV is the stock ticker symbol of Enovis Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Enovis Corporation (ENOV)?

As of Tue Apr 22 2025, market cap of Enovis Corporation is 1.86 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ENOV stock?

You can check ENOV's fair value in chart for subscribers.

Is Enovis Corporation a good stock to buy?

The fair value guage provides a quick view whether ENOV is over valued or under valued. Whether Enovis Corporation is cheap or expensive depends on the assumptions which impact Enovis Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ENOV.

What is Enovis Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 22 2025, ENOV's PE ratio (Price to Earnings) is -2.25 and Price to Sales (PS) ratio is 0.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ENOV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Enovis Corporation's stock?

In the past 10 years, Enovis Corporation has provided -0.089 (multiply by 100 for percentage) rate of return.